INOZYME PHARMA, INC. Management Fee Expense
INOZYME PHARMA, INC. reported Management Fee Expense of $400.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ManagementFeeExpense · last filed 2024-03-12
- INOZYME PHARMA, INC. management fee expense for the quarter ending 2021-03-31 was $400.00K.
- INOZYME PHARMA, INC. management fee expense for fiscal 2021 was $400.00K.
| Period end | Management Fee Expense | Management Fee Expense 3 month | Management Fee Expense 12 month |
|---|---|---|---|
| 2021-12-31 | $400.00K 10-K · filed 2023-03-22 | ||
| 2021-05-06 | $400.00K 10-K · filed 2024-03-12 | ||
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-10 |